Ciprofloxacin Extended-Release Tablets and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Ciprofloxacin Extended-Release Tablets and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ciprofloxacin
Brand name: Cipro, Cipro XR, Proquin XR, Cipro IV
Synonyms: Ciprofloxacin, Ciprofloxacin (Systemic)
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ciprofloxacin Extended-Release Tablets-Tilia Fe
- Ciprofloxacin Extended-Release Tablets-Tiludronate
- Ciprofloxacin Extended-Release Tablets-Timentin
- Ciprofloxacin Extended-Release Tablets-Timentin Add-Vantage
- Ciprofloxacin Extended-Release Tablets-Timentin Injection
- Ciprofloxacin Extended-Release Tablets-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Ciprofloxacin in 5% Dextrose
- Tildrakizumab-asmn Subcutaneous-Ciprofloxacin injection
- Tildrakizumab-asmn Subcutaneous-Ciprofloxacin Injection Concentrate
- Tildrakizumab-asmn Subcutaneous-Ciprofloxacin Intravenous
- Tildrakizumab-asmn Subcutaneous-Ciprofloxacin Oral Suspension
- Tildrakizumab-asmn Subcutaneous-Ciprofloxacin Tablets